SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
My trading buddies and I are considering buying Myriad Genetics. Please join me in a discussion of this company.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2355CS: CMS places BRACAnalysis on CLFS. In-line with our thesis, the Center for Medmopgcw-11/2/2012
2354Appeals Court Rules for Myriad on Gene Patents WASHINGTON—A divided federal apmopgcw-8/16/2012
2353supremes send the case back to the appeals court to review again in light of themopgcw-3/26/2012
2352supremes rule against Nestle on testing patent case; will be interesting to see mopgcw-3/20/2012
2351Myriad Genetics Acquires Exclusive Rights to RAD51C Gene RAD51C Increases a Patsim1-1/19/2012
2350MYGN 22nd Annual Oppenheimer Healthcare Conference Call December 14, 2011 Davidmopgcw-12/17/2011
2349Myriad Genetics secures option to buy Crescendo Biosciences On Thursday Septemsim1-9/9/2011
2348The name "Myrexis" is pretty awful as well.rkrw-9/8/2011
2347Somewhere around here? I made a comment, how tacky it was to assign a trade namescaram(o)uche-9/8/2011
2346up 25 cents?mopgcw-7/29/2011
2345$MYGN opinion is out: http://t.co/dhnAZfB CAFC full reversal on gene patents, psoftware salesperson-7/29/2011
2344Myriad Genetics: This Leading Developer of Diagnostic Products Is Catching The Esim1-7/20/2011
2343Smith & Nephew, HTC, Hurtigruten, Google, Denison: Intellectual Property [Mysim1-6/21/2011
2342Supreme Court to Consider Patents on Medical Tests JUNE 20, 2011, 4:34 P.M. ETsim1-6/20/2011
2341Auriga Downgrades Myriad Genetics (MYGN) to Hold on Valuation; Delayed Gratificabob zagorin-6/15/2011
2340Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Prosim1-5/26/2011
2339ASCO Abstract Saturday June 4, 2:00 PM to 6:00 PM Prognostic value of a 46-gesim1-5/26/2011
2338Myriad Genetics Announces Agreement to Acquire Rules-Based Medicine Acquisitionsim1-4/28/2011
2337Myriad Genetics Patent Appeal Case Arguments Begin April 4 By IB Times Staff Resim1-3/25/2011
2336MYGN May Shift From Patents To Proprietary Data (thanks to "Disambiguate&qsim1-3/5/2011
2335Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer Ousim1-2/9/2011
2334Gene test may cut need for prostate cancer surgery Tue Feb 8, 2011 7:01pm EST sim1-2/9/2011
2333Not necessarily a negative for MYGN 'Sanofi’s results and AstraZeneca’s triDoctor Zeus-1/30/2011
2332That's quite interesting, Stuart, it puts a possibly different perspective otom pope-1/28/2011
2331Myriad Test May Pinpoint Tumor Drug Success After Sanofi Medicine Failed By Rosim111/28/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News